* A corporate client of Hybridan LLP.
** Potential means Intention to Float (ITF) or similar announcement has been made.
***Arranged by type of listing and date of announcement.
****Alphabetically arranged and Closing Price on prior day to Publication.
Dish of the day
Admissions:
Metlen Energy & Metals (MTLN.L), a Greece-based Company primarily engaged in energy and metallurgical industries announced its Listing and Admission to trading of the Company's Euro denominated ordinary registered shares on the LSE Main Market and on the Regulated Securities Market of the Athens Exchange. The Company operates through two core business sectors: Energy and Metals. Within the Energy sector, the Company engages in development, construction, and operation of thermal units and renewable energy projects, as well as the design and construction of electric power infrastructure projects. The Company is also involved in retail electricity and natural gas supply, as well as provision of energy products and services, such as energy efficiency, smart cities services, and hydrogen infrastructure.
On Friday 1 August, Johnson Service Group (JSG.L) and Oakley Capital Investments (OCI.L) moved to the Main market from AIM.
Delistings:
Pod Point Group Holdings (PODP.L) has left the Main Market.
Good Life Plus (AQSE: GDLF) has left the Aquis market.
On Friday 1 August, Watchstone Group (AQSE: WTG) left the Aquis market.
What’s baking in the oven?
Potential** Initial Public Offerings:***
24th July: Scotch Corner Designer Village, a newly formed single asset real estate company (to be re-registered as a public limited company) which is developing a retail outlet and leisure destination, announces it may consider an IPO on the newly launched Aquis Real Asset Market (ARAM) of the Aquis Stock Exchange. Timing and deal details TBC.
Banquet Buffet****
Cobra Resources 2.60p £20.63m (COBR.L)
The mineral exploration and development Company advancing a Rare Earth Element (REE) discovery at its Boland Project in South Australia announced initial results from re-analysis of historical, uranium-focused rotary mud drilling from a recently acquired tenement (EL 6742) that covers over 750km square of the prospective Yaninee Palaeochannel system. Results indicate the presence of a REE system with characteristics reflective of Boland on the Narlaby Palaeochannel 10-20km to the northeast. This significantly increases the scale of the ionic REE system within the Pidinga Formation amenable to low-cost, low disturbance In Situ Recovery. Initial results define two large higher-grade zones exceeding 80km2 that flank the main incised channel, reflecting similar depositional geology to the Boland Prospect.
Creo Medical Group 13.13p £51.56m (CREO.L)
The medical device Company focused on the emerging field of minimally invasive surgical endoscopy for pre-cancer and cancer patients has issued a testimonial video from a patient who successfully underwent a procedure utilising Creo's Speedboat technology. Liz Thomas, the wife of one of the Creo engineers who helped to develop the innovative Speedboat technology, faced a major health challenge in late 2024 and was told the only option available to her was a full bowel resection, given that the Speedboat procedure was not available through NHS Wales at that time. Liz's husband, a software engineer for Creo before his retirement, was aware that Speedboat could be a treatment option and sought a second opinion.
She has made a successful recovery and returned to daily life within days of the procedure. Speedboat aims to provide significant clinical value to a rapidly increasing number of patients in the treatment of the early stages of colorectal cancer avoiding complex and impactful surgery.
Directa Plus 9.75p £10.34m (DCTA.L)
The producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets announces an update on trading for the six months to 30 June 2025 (H1 FY25). Based on its unaudited management accounts for H1 FY25, the Group expects to report a 15% increase in revenue to EUR3.9m (H1 FY24: EUR3.39m). This growth is accompanied by a significant improvement in profitability, with EBITDA losses expected to reduce by 40% to EUR1.0m (H1 FY24: EUR1.8m). This performance is in-line with management's expectations, reflecting a focus on high-value contracts, strong cost control, and operational efficiencies. The Board remains confident of meeting market expectations for Adjusted LBITDA in FY25.
Europa Oil & Gas (Holdings) 0.50p £4.80m (EOG.L)
The West Africa, UK, and Ireland focused oil and gas exploration, development, and production Company announced that its associated company, Antler Global Limited, has entered into detailed commercial discussions and has signed a non-binding Heads of Terms with a major energy company to farm-out an interest in the EG-08 production sharing contract (PSC) in offshore Equatorial Guinea. Europa has a 42.9% equity interest in Antler which in turn holds an 80% working interest in the EG-08 PSC, with the remaining 20% held by GEPetrol (Guinea Equatorial de Petroleos), the national oil company of Equatorial Guinea, representing the State's interest. Europa will provide further updates on the progress of the commercial discussions in due course.
Goldplat 6.75p £11.53m (GDP.L)
The Mining Services Company with international gold recovery operations located in South Africa and Ghana, servicing the African and South American Mining Industry, announced its intention to declare a dividend and provided an operational update for Q4 of the current financial year and a trading update for the current financial year ended 30 June 2025. The two recovery operations had their second best quarterly operational performance for FY2025, achieving a combined operating profit for Q4 of £1,670,000 (FYQ3 2025 - £694,000). During Q4 the two recovery operations achieved a combined profit before tax of £766,000 (FY Q3 2025 - £769,000). Despite a good operating quarter, the Board expects that the Group's results for FY2025 will be materially below current market expectations, with the adjusted profit before tax to be in the region of £2,600,000 (FY2024 £5,993,000) driven principally by changes in the business model in Ghana during the year and significant foreign exchange losses towards the end of the financial year.
Hamak Gold Limited 4.95p £22.38m (HAMA.L)
The Company combining traditional gold exploration in West Africa with a Digital Asset Treasury Management strategy announced the appointment of Nicola Horlick as a Non-Executive Director. Nicola will also join both the Audit Committee and the Remuneration Committee of the Board. Nicola Horlick is a prominent figure in the UK investment industry, with over 35 years of experience in institutional fund management, corporate governance, and financial innovation.
Premier African Minerals Ltd 0.03p £21.75m (PREM.L)
The multi-commodity mining and natural resource development Company announced an update on the plant status at the Zulu Lithium and Tantalum Project following the announcement on 25 July 2025. The second phase of the plant test run is now expected to commence on 4 August, with all necessary OEM's present. Operating parameters will be finalised and agreed with the Zulu team and OEM suppliers, to meet the required spodumene concentrate specifications. By operating within these parameters and optimising the remaining areas in the plant with guidance from the relevant OEM's, the plant should reach a sustained steady-state of operation. This would also enable Zulu to target the overall plant availability of 22 days per month as was originally projected as the required availability to meet target production levels.
Strip Tinning Holdings 27.50p £5.01m (STG.L)
The supplier of specialist connection systems to the automotive sector announced its unaudited results for the six months ended 30 June 2025. Total Revenues of £4.5m (H1 2024: £4.8m) and Adjusted EBITDA loss of £0.3m (H1 2024: loss of £0.8m). Cash generation from operations of £0.4m (H1 2024: £1.9m); cash balance of £0.1m (H1 2024: £2.0m) with a further £0.4m availability on the Invoice Discounting facility. The Board remains confident of meeting market expectations for Adjusted EBITDA in FY25.
Technology Minerals 0.11p £3.07m (TM1.L)
The Company involved in establishing a circular economy for battery metals announces that Recyclus Group, its 48.35% owned battery recycling business, has entered into a £1.1m loan agreement with Close Brothers Group. The funding will directly support the ongoing development and progression of the Wolverhampton plant, enabling Recyclus to scale production more rapidly. This investment is expected to enhance the plant's profitability, productivity, and operational efficiency, while also strengthening Recyclus' revenue streams as it continues to commercialise its recycling technology. The asset-backed loan is for a term of five years.
The life sciences Company focusing on early-stage cancer therapeutics and women's health provided an update on the commercial activity of its solely owned subsidiary Inaphaea BioLabs. Inaphaea announced the execution of an exclusive licence agreement with UK based Dominion Biotech Ltd for Inaphaea's PredictRx platform. PredictRx is a personalised cancer screening service whereby a patient's tumour sample is processed into Patient Derived Cells and subjected to a comprehensive drug combination screening panel to determine optimal chemotherapy treatment protocols. Under the terms of the Agreement, Inaphaea will receive a 50% share of global net revenues from the PredictRx service to be offered by Dominion.
This document has been provided as a general market commentary and is issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as investment advice; a recommendation; an offer to sell; nor solicitation of any offer to buy any security or other financial instrument. Nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. The information has been provided without taking into account the investment objective, financial situation or needs of any particular person. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
As market commentary, this document is not investment research or a research recommendation for regulatory purposes as it does not constitute substantive research or analysis. It is not subject to any prohibition on dealing ahead of the dissemination of investment research although Hybridan LLP maintains related internal systems and controls in connection with such dealing.
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result, both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
This document is not intended to be an invitation or inducement to engage in investment activity. In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are categorised by Hybridan LLP as either a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the avoidance of doubt, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. The information may contain projections or other forward-looking statements regarding future events, targets or expectations. There is no assurance that such events or expectations will be achieved, and actual results may be significantly different from that shown here. The information is based on current market conditions, which will fluctuate and may be superseded by subsequent market events or for other reasons. Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein.
References to specific securities, asset classes and financial markets are for illustrative purposes only. Past performance is no guarantee of future results. Information and opinions presented have been obtained or derived from sources which Hybridan LLP reasonably believed to be reliable however no representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any losses arising in any way from use of all or any part of the information in this document including, for the avoidance of doubt, direct or indirect or consequential loss or damage (including lost profits).
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication.
In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
Unless otherwise stated, Hybridan LLP owns the intellectual property rights and any other rights in this document. This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.